Pattern of dual antiplatelet use and 12-month outcomes stratified by bleeding and ischemic risk in acute coronary syndrome patients undergoing percutaneous coronary intervention

被引：0
|
作者：
Yan, B. [1 ]
Lai, A. [1 ]
Sun, H. [1 ]
Tam, T. K. [1 ]
Tan, G. M. [1 ]
机构：
[1] Chinese Univ Hong Kong, Hong Kong, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Treatment, Costs, and 12-Month Outcomes by GRACE Risk Score in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Mohacsi, Attila
    Niguez, Andres
    James, Stefan
    Ferrieres, Jean
    Pavlides, Gregory
    Sartral, Magali
    Belger, Mark
    Tomlin, Molly
    Norrbacka, Kirsi
    Fakhouri, Walid
    CIRCULATION, 2011, 124 (21)
  • [2] Bleeding versus ischemic risk during dual antiplatelet therapy on patients with acute coronary syndromes undergoing percutaneous coronary intervention
    Nau, Gerardo
    Lalor, Nicolas
    Pedernera, Gustavo
    Daquarti, Gustavo
    Spaletra, Pablo
    Candiello, Alfonsina
    Padilla, Lucio
    Trivi, Marcelo
    Cura, Fernando
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2016, 45 (02): : 67 - 72
  • [3] A UK Time Trends Analysis of Dual Antiplatelet Therapy Use and Bleeding in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Mahadevan, Kalaivani
    Harris, Jessica
    Pufulete, Maria
    Johnson, Tom
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B392 - B392
  • [4] Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Bavishi, Chirag
    Trivedi, Vrinda
    Singh, Mandeep
    Katz, Edward
    Messerli, Franz H.
    Bangalore, Sripal
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (11): : 1325.e1 - 1325.e12
  • [5] Three versus 12-month dual antiplatelet therapy duration in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
    Selvaraj, Vijairam
    Chatterjee, Saurav
    Hirai, Taishi
    Abbott, J. Dawn
    Bavishi, Chirag
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2022, 100 (07) : 1151 - 1158
  • [6] The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
    Tereshchenko, Andrei S.
    Merkulov, Evgeny, V
    Samko, Anatoly N.
    Abugov, Sergey A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2019, 15 (02) : 277 - 281
  • [7] TRIPLE VERSUS DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Hu, Bin
    Zhou, Yujie
    Liu, Yuyang
    Shi, Dongmei
    Zhao, Yingxin
    Jia, Dean
    HEART, 2010, 96 : A107 - A107
  • [8] Antiplatelet Therapy for Elderly Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Fioretti, Vincenzo
    Sperandeo, Luca
    Gerardi, Donato
    Di Fazio, Aldo
    Stabile, Eugenio
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (14)
  • [9] TRIPLE VERSUS DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION
    Hubin
    Zhouyujie
    Liuyuyang
    Shidongmei
    Zhaoyingxin
    Jiadean
    HEART, 2011, 97
  • [10] Inflammatory and Bleeding Risks on Clinical Outcomes in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
    Duan, Yixuan
    Qiu, Miaohan
    Na, Kun
    Liu, Daoshen
    Zhou, Shangxun
    Xu, Ying
    Qi, Zizhao
    Liu, Haiwei
    Xu, Kai
    Wang, Xiaozeng
    Li, Jing
    Li, Yi
    Han, Yaling
    THROMBOSIS AND HAEMOSTASIS, 2025,
12345